Keywords: بیماری آلزایمر پیش از قاعدگی; Autosomal Dominant Alzheimer's Disease; Alzheimer's Prevention Initiative; Adherence/Retention Plan; Crenezumab; Preclinical Alzheimer's disease;
مقالات ISI بیماری آلزایمر پیش از قاعدگی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری آلزایمر پیش از قاعدگی; Aging; Beta-amyloid; fMRI; Preclinical Alzheimer's disease; Nonlinear BOLD activation; Cognition;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Biomarkers; Risk factors;
Keywords: بیماری آلزایمر پیش از قاعدگی; Amyloid-β; Sleep; Neuropsychological performance; Mild cognitive impairment; Preclinical Alzheimer's disease;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; SNAP; CSF biomarkers; Cortical thickness; Structural cortical networks; White matter;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Cognitive composites; End-point validation;
Keywords: بیماری آلزایمر پیش از قاعدگی; Amyloid PET imaging; Depression; Anxiety; Truth disclosure; Diagnostic imaging; Preclinical Alzheimer's disease; Biomedical ethics; Safety;
Keywords: بیماری آلزایمر پیش از قاعدگی; Recruitment; Preclinical Alzheimer's disease; Clinical trials; Registries;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Systematic review; Cohort; Clinical trial; Longitudinal; Cross-sectional; Biomarker; Cognition; Familial Alzheimer's disease; Neuropathology;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Ribot temporal gradient; Famous face naming; Cerebral blood flow; Arterial spin labeling; Magnetic resonance imaging; Cognitive aging;
Keywords: بیماری آلزایمر پیش از قاعدگی; Delirium; Cortical thickness; Alzheimer's disease; Biomarker; Neurodegeneration; Atrophy; Preclinical Alzheimer's disease; Delirium severity;
Keywords: بیماری آلزایمر پیش از قاعدگی; Cognitive reserve; Preclinical Alzheimer's disease; Biomarkers; Cognitive change; Longitudinal;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Disclosure; Biomarker; Recruitment;
Keywords: بیماری آلزایمر پیش از قاعدگی; Amyloid; Hippocampus; Age; Preclinical Alzheimer's disease;
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease; Aging; MRI; PET; White matter; Leukoaraiosis; Preclinical Alzheimer's disease; Amyloid
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease; Amyloid imaging; Preclinical Alzheimer's disease; Mild cognitive impairment; Cognition; APOE;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; DTI; Brain network
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease; Practice effects; Cognition; Clinical trials; Serial assessment; Preclinical Alzheimer's disease; Neuropsychology
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Cerebrospinal fluid; Amyloid; Tau; Cognition; Biomarkers;
Keywords: بیماری آلزایمر پیش از قاعدگی; Subjective cognitive decline; Preclinical Alzheimer's disease; Early detection
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Prodromal Alzheimer's disease; Mild cognitive impairment; Diagnostic criteria; Food and Drug Administration; Regulatory guidance; Disease modification; Drug development; Clinical trials; Clinical outcomes; Composite scales
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer disease; Preclinical Alzheimer's disease; Early detection; Cholinergic; Cognition; Biomarkers; Diagnosis; Anticholinergic drugs; Scopolamine; β-Amyloid protein;
Keywords: بیماری آلزایمر پیش از قاعدگی; Subjective cognition; Preclinical Alzheimer's disease; Mild cognitive impairment; Cognitive aging;
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease; Subjective cognitive decline; Preclinical Alzheimer's disease; Mild cognitive impairment; Prodromal Alzheimer 's disease; Research criteria;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Cognition; Prevention; Clinical trials; Composite endpoints; Power; Sample size;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Cognitive aging; Age-related memory loss; Mild cognitive impairment; Apolipoprotein E; Longitudinal testing;
Keywords: بیماری آلزایمر پیش از قاعدگی; Cognitive reserve; Preclinical Alzheimer's disease; Mild cognitive impairment; Cerebrospinal fluid; Tau; Amyloid; Cohort studies; Biomarkers;
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease; Preclinical Alzheimer's disease; 5-Hydroxymethylcytosine; 5-Methylcytosine;
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Cognitive composite; Amyloid; Cognitive decline; Neuropsychological assessment
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
Keywords: بیماری آلزایمر پیش از قاعدگی; Cortical thickness; YKL-40; Neuroinflammation; Preclinical Alzheimer's disease; CSF biomarkers; Structural MRI;
No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Cortical amyloid load; Functional connectivity; EEG; PET;
Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Longitudinal cognitive change; Cholinergic basal forebrain; Hippocampus; Amyloid PET;
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's diseas
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease; Autosomal-dominant Alzheimer's disease; Preclinical Alzheimer's disease; Prevention; Clinical trial; Crenezumab; Alzheimer's Prevention Initiative;
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Amyloid; APOE; Sex; Gender; Cognitive decline;
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets
Keywords: بیماری آلزایمر پیش از قاعدگی; AD; Alzheimer's disease; Aβ42; amyloid beta; p-tau; phosphorylated tau; t-tau; total tau; Ctrl; control; preAD; preclinical Alzheimer's disease; HCB; Hospital Clinic Barcelona; ADNI; Alzheimer's Disease Neuroimaging Initiative; MMSE; Mini Mental State ex
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer's disease diagnosis; Preclinical Alzheimer's disease; Biomarkers Alzheimer's disease; CSF biomarkers Alzheimer's disease; Alzheimer's disease imaging; Amyloid PET; Tau PET;
Increasing beta-amyloid deposition in cognitively healthy aging predicts nonlinear change in BOLD modulation to difficulty
Keywords: بیماری آلزایمر پیش از قاعدگی; Aging; Beta-amyloid; fMRI; Preclinical Alzheimer's disease; Nonlinear BOLD activation; Cognition; N-Back;
Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease
Keywords: بیماری آلزایمر پیش از قاعدگی; Amyloid-β; Apolipoprotein E; Alzheimer's disease; [11C]PiB; PET; Preclinical Alzheimer's disease;
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease
Keywords: بیماری آلزایمر پیش از قاعدگی; Plasma amyloid β; Aβ; Alzheimer's disease; Dementia; Preclinical Alzheimer's disease; Biomarker;
Beneficial effect of bilingualism on Alzheimer's disease CSF biomarkers and cognition
Keywords: بیماری آلزایمر پیش از قاعدگی; Bilingualism; Preclinical Alzheimer's disease; CSF biomarkers; Cognitive performance; Cognitive/brain reserve; Cohort studies;
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
Keywords: بیماری آلزایمر پیش از قاعدگی; Amyloid β; Plasma amyloid β ratio; Biomarker; Preclinical Alzheimer's disease; β-Amyloid imaging; Positron emission tomography; Clinical trials;
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Harmonization; Longitudinal follow-up; Cognitive testing; Diagnostic classification;
Featured ArticleEarly and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Secondary prevention; Cognitive composite; Amyloid PET; Longitudinal cognitive decline;
Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis
Keywords: بیماری آلزایمر پیش از قاعدگی; Cognition; Amyloid-beta; Impairment; Decline; Meta-analysis; Preclinical Alzheimer's disease;
Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults
Keywords: بیماری آلزایمر پیش از قاعدگی; Insulin; Glycated hemoglobin; Preclinical Alzheimer's disease; Cerebral amyloid burden; Neurodegeneration;
Disclosure of positron emission tomography amyloid imaging results: AÂ preliminary study of safety and tolerability
Keywords: بیماری آلزایمر پیش از قاعدگی; Alzheimer disease; Preclinical Alzheimer's disease; Early detection; PET imaging; Amyloid; Biomarkers; Diagnosis; Amyloid-beta protein; Ethics; Disclosure;
Featured ArticleBlood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Biomarker; Metabolomics; Phospholipids; Machine learning;
Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial
Keywords: بیماری آلزایمر پیش از قاعدگی; Cognitive composite score; Clinical relevance; Prevention; Preclinical Alzheimer's disease; Cognition; Dementia; Clinical trials; Outcome measures; Power;
APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease
Keywords: بیماری آلزایمر پیش از قاعدگی; Beta-amyloid; Apolipoprotein E; Cognitive decline; Preclinical Alzheimer's disease; Memory;
Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease
Keywords: بیماری آلزایمر پیش از قاعدگی; Preclinical Alzheimer's disease; Early diagnosis; Acetylcholine; Biomarker; Cognition;